Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600568.SS Stock Summary
In the News
600568.SS Financial details
Company Rating
Neutral
Market Cap
2.75B
Income
-1.01B
Revenue
507.2M
Book val./share
1.28
Cash/share
0.27
Dividend
-
Dividend %
-
Employees
1.42K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2021
P/E
-3.33
Forward P/E
-
PEG
-0.09
P/S
6.6
P/B
1.32
P/C
5.11
P/FCF
-4.22
Quick Ratio
2.52
Current Ratio
4.18
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.51
EPS next Y
-
EPS next Q
-
EPS this Y
263.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.06%
Revenue last 5Y
-2.45%
Revenue Q/Q
-6.09%
EPS Q/Q
-93.09%
-
-
-
-
SMA20
-8.05%
SMA50
-18.93%
SMA100
-20.35%
Inst Own
-
Inst Trans
-
ROA
-32%
ROE
-38%
ROC
-0.37%
Gross Margin
27%
Oper. Margin
-203%
Profit Margin
-198%
Payout
-1%
Shs Outstand
1.99B
Shs Float
1.81B
-
-
-
-
Target Price
-
52W Range
1.33-1.97
52W High
+38%
52W Low
+38%
RSI
42.78
Rel Volume
0.68
Avg Volume
4.77M
Volume
3.24M
Perf Week
-1.43%
Perf Month
-4.83%
Perf Quarter
-
Perf Half Y
-25.81%
-
-
-
-
Beta
0.42
-
-
Volatility
0.02%, 0.06%
Prev Close
0.73%
Price
1.38
Change
3.76%
600568.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.29 | 0.35 | 0.37 | 0.3 | 0.25 | |
Net income per share | -0.96 | -0.18 | 0.01 | -0.11 | -0.4 | |
Operating cash flow per share | -0.13 | 0.31 | 0.12 | 0.05 | 0.01 | |
Free cash flow per share | -0.22 | -0.08 | 0.07 | 0.02 | 0 | |
Cash per share | 0.33 | 0.21 | 0.15 | 0.34 | 0.31 | |
Book value per share | 2.03 | 1.85 | 1.9 | 1.87 | 1.4 | |
Tangible book value per share | 1.95 | 1.79 | 1.86 | 1.84 | 1.39 | |
Share holders equity per share | 2.03 | 1.85 | 1.9 | 1.87 | 1.4 | |
Interest debt per share | 0.14 | 0.07 | 0.02 | 0.16 | 0.14 | |
Market cap | 4.62B | 3.49B | 2.77B | 3.76B | 3.75B | |
Enterprise value | 3.86B | 3.02B | 2.11B | 3.52B | 3.44B | |
P/E ratio | -2.41 | -9.57 | 189.85 | -18.06 | -4.73 | |
Price to sales ratio | 8.07 | 5.01 | 3.81 | 6.48 | 7.4 | |
POCF ratio | -17.27 | 5.67 | 11.16 | 40.03 | 146.78 | |
PFCF ratio | -10.58 | -23.09 | 18.66 | 121.27 | -8.73K | |
P/B Ratio | 1.14 | 0.95 | 0.73 | 1.05 | 1.34 | |
PTB ratio | 1.14 | 0.95 | 0.73 | 1.05 | 1.34 | |
EV to sales | 6.75 | 4.34 | 2.9 | 6.06 | 6.8 | |
Enterprise value over EBITDA | -12.28 | 18.75 | 16.46 | 55.65 | -36.2 | |
EV to operating cash flow | -14.43 | 4.91 | 8.5 | 37.44 | 134.87 | |
EV to free cash flow | -8.84 | -19.98 | 14.2 | 113.43 | -8.02K | |
Earnings yield | -0.41 | -0.1 | 0.01 | -0.06 | -0.21 | |
Free cash flow yield | -0.09 | -0.04 | 0.05 | 0.01 | 0 | |
Debt to equity | 0.07 | 0.04 | 0.01 | 0.08 | 0.1 | |
Debt to assets | 0.05 | 0.03 | 0.01 | 0.06 | 0.07 | |
Net debt to EBITDA | 2.41 | -2.92 | -5.16 | -3.85 | 3.2 | |
Current ratio | 5.41 | 3.03 | 4.57 | 4.73 | 3.97 | |
Interest coverage | -4.97 | 10.98 | 9.28 | -2.42 | -12.67 | |
Income quality | 0.14 | -1.69 | 17.01 | -0.45 | -0.03 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.03 | -0.03 | 0.3 | -0.01 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.12 | 0.1 | 0.08 | 0.1 | |
Research and developement to revenue | 0.1 | 0.09 | 0.03 | 0.04 | 0.04 | |
Intangibles to total assets | 0.07 | 0.07 | 0.06 | 0.04 | 0.04 | |
Capex to operating cash flow | 0.63 | -1.25 | -0.4 | -0.67 | -1.02 | |
Capex to revenue | -0.3 | -1.1 | -0.14 | -0.11 | -0.05 | |
Capex to depreciation | -2.87 | -10.7 | -1.21 | -0.62 | -0.26 | |
Stock based compensation to revenue | 0 | 0.06 | 0.01 | 0 | -0.08 | |
Graham number | 6.63 | 2.76 | 0.56 | 2.14 | 3.54 | |
ROIC | -0.01 | 0.02 | 0 | -0.01 | -0.06 | |
Return on tangible assets | -0.37 | -0.08 | 0 | -0.05 | -0.22 | |
Graham Net | 0.41 | 0.18 | 0.25 | 0.32 | 0.27 | |
Working capital | 3.29B | 1.45B | 1.64B | 1.5B | 1.38B | |
Tangible asset value | 3.88B | 3.56B | 3.71B | 3.54B | 2.78B | |
Net current asset value | 2.67B | 1.28B | 1.55B | 1.17B | 1.06B | |
Invested capital | 0.07 | 0.04 | 0.01 | 0.08 | 0.1 | |
Average receivables | 1.37B | 978.46M | 583.22M | 541.22M | 515.87M | |
Average payables | 200.52M | 151.67M | 118.29M | 112.43M | 101.04M | |
Average inventory | 1.04B | 876.21M | 710.35M | 650.35M | 636.44M | |
Days sales outstanding | 866.53 | 312.96 | 285.76 | 322.18 | 374.28 | |
Days payables outstanding | 157.5 | 83.98 | 75.62 | 97.55 | 87.95 | |
Days of inventory on hand | 863.36 | 521.75 | 437.2 | 564.61 | 608.67 | |
Receivables turnover | 0.42 | 1.17 | 1.28 | 1.13 | 0.98 | |
Payables turnover | 2.32 | 4.35 | 4.83 | 3.74 | 4.15 | |
Inventory turnover | 0.42 | 0.7 | 0.83 | 0.65 | 0.6 | |
ROE | -0.47 | -0.1 | 0 | -0.06 | -0.28 | |
Capex per share | -0.08 | -0.38 | -0.05 | -0.03 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | |
Net income per share | -0.01 | -0.38 | -0.01 | -0.11 | -0.01 | |
Operating cash flow per share | -0.01 | -0.38 | -0.01 | 0.03 | -0.03 | |
Free cash flow per share | -0.01 | -0.38 | -0.01 | 0.03 | -0.03 | |
Cash per share | 0.3 | 0.31 | 0.28 | 0.3 | 0.27 | |
Book value per share | 1.82 | 1.4 | 1.39 | 1.29 | 1.28 | |
Tangible book value per share | 1.79 | 1.39 | 1.39 | 1.27 | 1.26 | |
Share holders equity per share | 1.82 | 1.4 | 1.39 | 1.29 | 1.28 | |
Interest debt per share | 0.14 | 0.14 | 0.14 | 0.01 | 0.01 | |
Market cap | 3.36B | 3.75B | 3.44B | 3.46B | 3.67B | |
Enterprise value | 3.08B | 3.44B | 3.2B | 2.92B | 3.2B | |
P/E ratio | -42.96 | -1.24 | -39.36 | -4.05 | -60.41 | |
Price to sales ratio | 26.47 | 29.65 | 29.19 | 25.5 | 28.79 | |
POCF ratio | -171.84 | -4.96 | -157.42 | 63.75 | -70.17 | |
PFCF ratio | -144.64 | -4.94 | -127.2 | 67.42 | -64.74 | |
P/B Ratio | 0.95 | 1.34 | 1.24 | 1.35 | 1.44 | |
PTB ratio | 0.95 | 1.34 | 1.24 | 1.35 | 1.44 | |
EV to sales | 24.2 | 27.25 | 27.16 | 21.49 | 25.13 | |
Enterprise value over EBITDA | -119.55 | -20.15 | -131.05 | -60.2 | -324.82 | |
EV to operating cash flow | -157.11 | -4.56 | -146.46 | 53.73 | -61.25 | |
EV to free cash flow | -132.23 | -4.54 | -118.34 | 56.82 | -56.52 | |
Earnings yield | -0.01 | -0.2 | -0.01 | -0.06 | 0 | |
Free cash flow yield | -0.01 | -0.2 | -0.01 | 0.01 | -0.02 | |
Debt to equity | 0.08 | 0.1 | 0.1 | 0.01 | 0.01 | |
Debt to assets | 0.06 | 0.07 | 0.08 | 0.01 | 0.01 | |
Net debt to EBITDA | 11.21 | 1.78 | 9.81 | 11.22 | 47.26 | |
Current ratio | 5.12 | 3.97 | 4.32 | 3.91 | 4.18 | |
Interest coverage | 2.19 | -50.28 | -2.83 | -1.09K | 60.43 | |
Income quality | 1 | 1 | 1 | -0.25 | 3.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | -0.04 | 0 | |
Sales general and administrative to revenue | 0.67 | -0.46 | 0.41 | -0.17 | 0.85 | |
Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.02 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | |
Capex to operating cash flow | 0.19 | 0 | 0.24 | -0.05 | 0.08 | |
Capex to revenue | -0.03 | -0.03 | -0.04 | -0.02 | -0.03 | |
Capex to depreciation | -0.13 | -0.12 | -0.22 | -0.13 | 0.1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.64 | 3.46 | 0.59 | 1.76 | 0.47 | |
ROIC | 0 | -0.22 | -0.01 | -0.08 | -0.01 | |
Return on tangible assets | 0 | -0.21 | -0.01 | -0.07 | -0.01 | |
Graham Net | 0.34 | 0.27 | 0.27 | 0.4 | 0.39 | |
Working capital | 1.53B | 1.38B | 1.36B | 1.37B | 1.37B | |
Tangible asset value | 3.5B | 2.78B | 2.76B | 2.53B | 2.52B | |
Net current asset value | 1.21B | 1.06B | 1.05B | 1.3B | 1.3B | |
Invested capital | 0.08 | 0.1 | 0.1 | 0.01 | 0.01 | |
Average receivables | 557.19M | 540.7M | 519.74M | 529.35M | 539.77M | |
Average payables | 94.78M | 92.6M | 92.01M | 90.76M | 86.32M | |
Average inventory | 656.91M | 645.93M | 635.58M | 637.08M | 637.19M | |
Days sales outstanding | 398.24 | 369.6 | 397.71 | 356.99 | 382.56 | |
Days payables outstanding | 92.94 | 75.11 | 107.77 | 84.4 | 83.66 | |
Days of inventory on hand | 653.25 | 519.8 | 743.09 | 603.43 | 638.09 | |
Receivables turnover | 0.23 | 0.24 | 0.23 | 0.25 | 0.24 | |
Payables turnover | 0.97 | 1.2 | 0.84 | 1.07 | 1.08 | |
Inventory turnover | 0.14 | 0.17 | 0.12 | 0.15 | 0.14 | |
ROE | -0.01 | -0.27 | -0.01 | -0.08 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
600568.SS Frequently Asked Questions
What is Zhongzhu Healthcare Holding Co.,Ltd stock symbol ?
Zhongzhu Healthcare Holding Co.,Ltd is a CN stock and trading under the symbol 600568.SS
What is Zhongzhu Healthcare Holding Co.,Ltd stock quote today ?
Zhongzhu Healthcare Holding Co.,Ltd stock price is $1.38 today.
Is Zhongzhu Healthcare Holding Co.,Ltd stock public?
Yes, Zhongzhu Healthcare Holding Co.,Ltd is a publicly traded company.